New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN and the TECOS Cardiovascular Safety Trial of JANUVIA Will Be Presented at the European Society of Cardiology Congress
August 20, 2015 at 08:31 AM EDT
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new analyses from the investigational ...
